Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ABEO

Updated 10/6/2026, 11:12 AM ET.

ABEO

ABEONA THERAPEUTICS INC.

Sale$101,091

Seshadri Vishwas

Chief Executive Officer, Director

19,608 shat $5.16Filed Sep 29, 9:48 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$47,385

Vazzano Joseph Walter

Chief Financial Officer

9,191 shat $5.16Filed Sep 29, 9:48 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$34,682

O'Malley Brendan M.

SVP, Chief Legal Officer

6,727 shat $5.16Filed Sep 29, 9:48 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$25,273

Vasanthavada Madhav

Chief Commercial Officer

4,902 shat $5.16Filed Sep 29, 9:47 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$87,966

Alvino Mark

Director

15,000 shat $5.86Filed Sep 1, 5:48 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$9,651

Vazzano Joseph Walter

Chief Financial Officer

1,478 shat $6.53Filed Jul 22, 4:30 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$173,257

Vazzano Joseph Walter

Chief Financial Officer

24,880 shat $6.96Filed Jul 9, 7:24 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$473,330

Seshadri Vishwas

Chief Executive Officer, Director

67,971 shat $6.96Filed Jul 9, 7:22 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$83,913

O'Malley Brendan M.

SVP, Chief Legal Officer

12,050 shat $6.96Filed Jul 9, 7:20 PM ETFiling
ABEO

ABEONA THERAPEUTICS INC.

Sale$87,784

Vasanthavada Madhav

Chief Commercial Officer

12,606 shat $6.96Filed Jul 9, 7:17 PM ETFiling

Read from public SEC filings. Not financial advice.